CinRx Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • CinRx's estimated annual revenue is currently $3.3M per year.(i)
  • CinRx's estimated revenue per employee is $155,000

Employee Data

  • CinRx has 21 Employees.(i)
  • CinRx grew their employee count by 5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M6-14%N/AN/A
#2
$1.7M110%N/AN/A
#3
$0.9M6200%N/AN/A
#4
$4M2618%N/AN/A
#5
$63.6M410-9%N/AN/A
#6
$2.5M1623%N/AN/A
#7
$1.1M740%N/AN/A
#8
$12.7M82-7%N/AN/A
#9
$0.9M6200%N/AN/A
#10
$1M13-58%$193MN/A
Add Company

CinRx Pharma is a multi-asset biotech company focusing on advancing novel therapeutics that address large unmet medical needs. CinRx acquires compounds from large pharma, biotech companies, academia, or by repurposing existing formulations that are available in the generic space. The compounds are developed using CinRx's formulation, pre-clinical, and CMC expertise in conjunction with Medpace, Inc., a global CRO. CinRx is led by Jon Isaacsohn, MD, former CMO of Teva Pharmaceutical's branded division, Catherine Soldano, former VP at Teva's New Therapeutic Entity (NTE) group, and Piyush Patel, PhD, former Senior Director of Product Development at Teva Pharmaceutical and Director of Formulation Development at Cephalon.

keywords:N/A

N/A

Total Funding

21

Number of Employees

$3.3M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.7M21-30%N/A
#2
$3.7M21-19%N/A
#3
$1.8M215%N/A
#4
$3.3M21-5%N/A
#5
$2.1M21-12%N/A